EACR 2026

The 2026 Annual Congress of the European Association for Cancer Research (EACR 2026) is dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.
8 June 2026
to 11 June 2026
Hungexpo
, Budapest
, Hungary

Visit biomodal at booth 

#53

About the event

Genetics alone doesn’t tell the full story. Join us to explore the 6‑base genome—where 5‑methylcytosine (5mC) and 5‑hydroxymethylcytosine (5hmC) reveal a cell’s dynamic state and early signals of change, helping you predict the future. Visit booth to learn:

One Solution: How duet multiomics solution evoC delivers 6‑base data with unrivaled sensitivity and specificity in a single workflow

Why conventional sequencing methods aren’t enough: What standard approaches overlook in methylation state changes and gene regulation.

Early indicators of disease: How 5hmCand 5mC patterns illuminate activation and identity—and why that matters for detection.

Would you like to meet up in person? Book your onsite meeting with one of our biomodal attendees by filling out the form below. ⬇️

Presenting at the event

Get it all in one workflow: Use duet cfDNA solutions to detect cancer earlier, monitor treatment response and understand tumour biology

Tuesday 09 June 2026 from 13:30 - 14:15​ @ Room F6+F7+F8​

This session, sponsored by biomodal, will introduce the duet cfDNA solutions as complete integrated genetic and epigenetic workflows and software. The duet cfDNA solutions unlock the broadest spectrum of biomarkers, with market leading accuracy, from a single low input cfDNA sample, enabling ultra-low LoD for the detection of ctDNA.

Talks will demonstrate how, in a liquid biopsy setting, 6-base data detects cancers earlier than other methylation sequencing approaches across multiple cohorts. Additional data will show how 6-base data enables a better understanding biological mechanisms of prostate cancer treatment response than existing liquid biopsy approaches.

In partnership with

Find the venue

One sample. One workflow. One solution.

Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.

Cancer research

Discover how alterations in DNA methylation play a crucial role in cancer research via gene expression changes and mutation occurrence. Learn more.

Discover more

Attending from biomodal

Dirk Bartels

Dirk Bartels, PhD

Business Development Manager
Leonardo Motta

Leonardo Motta

Territory Account Manager – UK, Ireland & Nordics
Tom Charlesworth

Tom Charlesworth, PhD

Director of Market Strategy and Corporate Development

Register now

Meet our team at the event

EACR 2026 8-11JUN26
392656668864

Stay up to date

Explore recent biomodal news and the events that we’ll be attending in the near future.

What are you looking for?